SCOPUS 정보 검색 플랫폼

Neuroscience Bulletin

Volumn 26, Issue 1, 2010, Pages 85-89

Research advancement in immunopathogenesis of myasthenia gravis

(2) Huang, Sha a Tan, Li Ming a

a CENTRAL SOUTH UNIVERSITY (China)

Author keywords

Immunological pathogenesis; Myasthenia gravis

Indexed keywords

AUTOANTIBODY; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CXCL13 CHEMOKINE; ETANERCEPT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; NICOTINIC RECEPTOR; RYANODINE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN BINDING; AUTOIMMUNITY; B LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; HELPER CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INHERITANCE; MYASTHENIA GRAVIS; PROTEIN EXPRESSION; PROTEIN TARGETING; REGULATORY T LYMPHOCYTE; SHORT SURVEY; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; AUTOANTIBODIES; CHEMOKINES; CYTOKINES; HUMANS; LYMPHOCYTES; MYASTHENIA GRAVIS;

EID: 76649136147 PISSN: 16737067 EISSN: None Source Type: Journal
DOI: 10.1007/s12264-010-0604-1 Document Type: Short Survey

Times cited : (5)

References (25)

1
- 33645533248
- Titin and ryanodine receptor antibodies in myasthenia gravis
- 10.1111/j.1600-0404.2006.00608.x
- G.O. Skeie J.A. Aarli N.E. Gilhus 2006 Titin and ryanodine receptor antibodies in myasthenia gravis Acta Neurol Scand S183 19 23 10.1111/j.1600-0404.2006.00608.x
- (2006) Acta Neurol Scand , vol.183 , pp. 19-23
- Skeie, G.O.¹ Aarli, J.A.² Gilhus, N.E.³

2
- 62549113408
- Autoantibody to dihydropyridine receptor in myasthenia gravis
- 10.1016/j.jneuroim.2009.01.001 1:CAS:528:DC%2BD1MXjsV2mtbc%3D 19187971
- T. Maruta H. Yoshikawa S. Fukasawa S. Umeshita Y. Inaoka S. Edahiro, et al. 2009 Autoantibody to dihydropyridine receptor in myasthenia gravis J Neuroimmunol 208 1-2 125 129 10.1016/j.jneuroim.2009.01.001 1:CAS:528: DC%2BD1MXjsV2mtbc%3D 19187971
- (2009) J Neuroimmunol , vol.208 , Issue.12 , pp. 125-129
- Maruta, T.¹ Yoshikawa, H.² Fukasawa, S.³ Umeshita, S.⁴ Inaoka, Y.⁵ Edahiro, S.⁶

3
- 34147103812
- + B helper T cells in autoimmune myasthenia gravis
- DOI 10.1002/eji.200636449
- B. Tackenberg J. Kruth J.E. Bartholomaeus K. Schlegel W.H. Oertel N. Willcox, et al. 2007 Clonal expansions of CD4+ B helper T cells in autoimmune myasthenia gravis Eur J Immunol 37 3 849 863 10.1002/eji.200636449 1:CAS:528:DC%2BD2sXjs1Sjt78%3D 17323412 (Pubitemid 46916951)
- (2007) European Journal of Immunology , vol.37 , Issue.3 , pp. 849-863
- Tackenberg, B.¹ Kruth, J.² Bartholomaeus, J.E.³ Schlegel, K.⁴ Oertel, W.H.⁵ Willcox, N.⁶ Hemmer, B.⁷ Sommer, N.⁸

4
- 36849010574
- - regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand
- DOI 10.1073/pnas.0708577104
- + regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand Proc Natl Acad Sci U S A 104 44 17459 17464 10.1073/pnas.0708577104 1:CAS:528:DC%2BD2sXht1ymtrbL 17956982 (Pubitemid 350219860)
- (2007) Proceedings of the National Academy of Sciences of the United States of America , vol.104 , Issue.44 , pp. 17459-17464
- Ben-David, H.¹ Sharabi, A.² Dayan, M.³ Sela, M.⁴ Mozes, E.⁵

5
- 34147199608
- Th17 cell induction and immune regulatory effects
- DOI 10.1002/jcp.20973
- Y.J. Bi G.W. Liu R.F. Yang 2007 Th17 cell induction and immune regulatory effects J Cell Physiol 211 273 278 10.1002/jcp.20973 1:CAS:528: DC%2BD2sXktVSrtr8%3D 17311299 (Pubitemid 46580080)
- (2007) Journal of Cellular Physiology , vol.211 , Issue.2 , pp. 273-278
- Bi, Y.¹ Liu, G.² Yang, R.³

6
- 46049111181
- Th17 and allergy
- DOI 10.2332/allergolint.R-07-160
- K. Oboki T. Ohno H. Saito S. Nakae 2008 Th17 and allergy Allergol Int 57 121 134 10.2332/allergolint.R-07-160 1:CAS:528:DC%2BD1cXotFGhsrY%3D 18427165 (Pubitemid 351897666)
- (2008) Allergology International , vol.57 , Issue.2 , pp. 121-134
- Oboki, K.¹ Ohno, T.² Saito, H.³ Nakae, S.⁴

7
- 34147150928
- Interleukin-17: A new paradigm in inflammation, autoimmunity, and therapy
- 10.1902/jop.2007.060392 17539723
- J.M. Kramer S.L. Gaffen 2007 Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy J Periodontol 78 1083 1093 10.1902/jop.2007.060392 17539723
- (2007) J Periodontol , vol.78 , pp. 1083-1093
- Kramer, J.M.¹ Gaffen, S.L.²

8
- 29144487073
- + T regulatory cells in the prevention of autoimmune myasthenia
- 1:CAS:528:DC%2BD2MXht12jtrfJ 16339525
- + T regulatory cells in the prevention of autoimmune myasthenia J Immunol 175 7898 7904 1:CAS:528:DC%2BD2MXht12jtrfJ 16339525
- (2005) J Immunol , vol.175 , pp. 7898-7904
- Liu, R.¹ La Cava, A.² Bai, X.F.³ Jee, Y.⁴ Price, M.⁵ Campagnolo, D.I.⁶

9
- 77954832333
- + T cells in the mechanism of myasthenia gravis in children and adults
- 1:CAS:528:DC%2BD1MXhtFyrs7fO
- + T cells in the mechanism of myasthenia gravis in children and adults Chin Med J 88 45 3189 3191 1:CAS:528: DC%2BD1MXhtFyrs7fO
- (2008) Chin Med J , vol.88 , Issue.45 , pp. 3189-3191
- He, X.T.¹ Liu, W.B.² Feng, H.Y.³ Zhang, Y.⁴ Huang, X.⁵ Meng, R.⁶

10
- 64049108521
- BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO
- 10.1002/eji.200838729 1:CAS:528:DC%2BD1MXktVaisbw%3D 19283707
- Q.F. Kong B. Sun G.Y. Wang D.X. Zhai L.L. Mu D.D. Wang, et al. 2009 BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO Eur J Immunol 39 800 809 10.1002/eji.200838729 1:CAS:528:DC%2BD1MXktVaisbw%3D 19283707
- (2009) Eur J Immunol , vol.39 , pp. 800-809
- Kong, Q.F.¹ Sun, B.² Wang, G.Y.³ Zhai, D.X.⁴ Mu, L.L.⁵ Wang, D.D.⁶

11
- 33748048186
- B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target
- DOI 10.1016/j.pharmthera.2006.03.005, PII S0163725806000428
- M.C. Dalakas 2006 B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target Pharmacol Ther 112 1 57 70 10.1016/j.pharmthera.2006.03.005 1:CAS:528:DC%2BD28XptFCit7s%3D 16644016 (Pubitemid 44301485)
- (2006) Pharmacology and Therapeutics , vol.112 , Issue.1 , pp. 57-70
- Dalakas, M.C.¹

12
- 33845303923
- Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland
- DOI 10.1016/j.mehy.2006.06.057, PII S0306987706005500
- P. Sassano F. Paparo V. Ramieri W. Colangeli G. Verdino 2007 Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland Med Hypotheses 68 2 314 317 10.1016/j.mehy.2006.06.057 1:CAS:528:DC%2BD28Xht12qt7jN 16997495 (Pubitemid 44879814)
- (2007) Medical Hypotheses , vol.68 , Issue.2 , pp. 314-317
- Sassano, P.¹ Paparo, F.² Ramieri, V.³ Colangeli, W.⁴ Verdino, G.⁵

13
- 17444370887
- Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment
- DOI 10.1016/j.jaut.2005.01.013
- E. Tüzün M.N. Meriggioli J. Rowin H. Yang P. Christadoss 2005 Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit from etanercept treatment J Autoimmun 24 3 261 268 10.1016/j.jaut.2005.01.013 15848049 (Pubitemid 40545889)
- (2005) Journal of Autoimmunity , vol.24 , Issue.3 , pp. 261-268
- Tuzun, E.¹ Meriggioli, M.N.² Rowin, J.³ Yang, H.⁴ Christadoss, P.⁵

14
- 33750442235
- The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis
- DOI 10.1016/j.cellimm.2006.08.005, PII S0008874906001353
- B.G. Xiao R.S. Duan W.H. Zhu C.Z. Lu 2006 The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis Cell Immunol 241 2 95 101 10.1016/j.cellimm.2006.08.005 1:CAS:528:DC%2BD28XhtFKmtbjM 17005165 (Pubitemid 44648025)
- (2006) Cellular Immunology , vol.241 , Issue.2 , pp. 95-101
- Xiao, B.-G.¹ Duan, R.-S.² Zhu, W.-H.³ Lu, C.-Z.⁴

15
- 35148895179
- High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis
- DOI 10.1080/00207450601125840, PII 782796185
- Z. Yapici E. Tüzün V. Altunayoolu A. Erdooan M. Eraksoy 2007 High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis Int J Neurosci 117 11 1505 1512 10.1080/00207450601125840 1:CAS:528:DC%2BD2sXhtFWqsr7N 17917921 (Pubitemid 47537037)
- (2007) International Journal of Neuroscience , vol.117 , Issue.11 , pp. 1505-1512
- Yapici, Z.¹ Tuzun, E.² Altunayoglu, V.³ Erdogan, A.⁴ Eraksoy, M.⁵

16
- 15244362030
- Long-term effects of IFN-γ, IL-10, and TGF-β-modulated dendritic cells on immune response in Lewis rats
- DOI 10.1007/s10875-005-0357-4
- R.S. Duan H. Link B.G. Xiao 2005 Long-term effects of IFN-gamma, IL-10, and TGF-β-modulated dendritic cells on immune response in Lewis rats J Clin Immunol 25 1 50 56 10.1007/s10875-005-0357-4 1:CAS:528:DC%2BD2MXhslGnsLg%3D 15742157 (Pubitemid 40386178)
- (2005) Journal of Clinical Immunology , vol.25 , Issue.1 , pp. 50-56
- Duan, R.-S.¹ Link, H.² Xiao, B.-G.³

17
- 67349177784
- Interleukin-10 promoter polymorphisms in myasthenia gravis
- 10.1016/j.jneuroim.2009.02.009 1:CAS:528:DC%2BD1MXlvF2ltL8%3D 19299022
- E.H. Alseth H.L. Nakkestad J. Aarseth N.E. Gilhus G.O. Skeie 2009 Interleukin-10 promoter polymorphisms in myasthenia gravis J Neuroimmunol 210 1-2 63 66 10.1016/j.jneuroim.2009.02.009 1:CAS:528:DC%2BD1MXlvF2ltL8%3D 19299022
- (2009) J Neuroimmunol , vol.210 , Issue.12 , pp. 63-66
- Alseth, E.H.¹ Nakkestad, H.L.² Aarseth, J.³ Gilhus, N.E.⁴ Skeie, G.O.⁵

18
- 76649120636
- CCR2-64I and CCR5Delta32 polymorphisms in Korean patients with myasthenia gravis
- 10.3988/jcn.2007.3.3.133 1:CAS:528:DC%2BD2sXht1CrtrvJ
- H.S. Kim D.S. Kim E.Y. Lee I.N. Sunwoo Y.C. Choi 2007 CCR2-64I and CCR5Delta32 polymorphisms in Korean patients with myasthenia gravis J Clin Neural 3 3 133 138 10.3988/jcn.2007.3.3.133 1:CAS:528:DC%2BD2sXht1CrtrvJ
- (2007) J Clin Neural , vol.3 , Issue.3 , pp. 133-138
- Kim, H.S.¹ Kim, D.S.² Lee, E.Y.³ Sunwoo, I.N.⁴ Choi, Y.C.⁵

19
- 64549137203
- Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-γ inducible protein 10 (IP-10) and its receptor CXCR3
- 10.1016/j.jneuroim.2009.01.021 1:CAS:528:DC%2BD1MXkslOksbk%3D 19232748
- T. Feferman R. Aricha K. Mizrachi E. Geron R. Alon M.C. Souroujon, et al. 2009 Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-γ inducible protein 10 (IP-10) and its receptor CXCR3 J Neuroimmunol 209 1-2 87 95 10.1016/j.jneuroim.2009.01.021 1:CAS:528:DC%2BD1MXkslOksbk%3D 19232748
- (2009) J Neuroimmunol , vol.209 , Issue.12 , pp. 87-95
- Feferman, T.¹ Aricha, R.² Mizrachi, K.³ Geron, E.⁴ Alon, R.⁵ Souroujon, M.C.⁶

20
- 50549100122
- + monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity
- 10.1002/eji.200737973 1:CAS:528:DC%2BD1cXovFWnu7o%3D 18581322
- + monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity Eur J Immunol 38 7 1877 1888 10.1002/eji.200737973 1:CAS:528:DC%2BD1cXovFWnu7o%3D 18581322
- (2008) Eur J Immunol , vol.38 , Issue.7 , pp. 1877-1888
- Bai, Y.¹ Liu, R.² Huang, D.³ La Cava, A.⁴ Tang, Y.Y.⁵ Iwakura, Y.⁶

21
- 33745939483
- The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
- DOI 10.1182/blood-2005-06-2383
- A. Meraouna G. Cizeron-Clairac R.L. Panse J. Bismuth F. Truffault C. Tallaksen, et al. 2006 The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis Blood 108 2 432 440 10.1182/blood-2005-06-2383 1:CAS:528:DC%2BD28XntFehtrc%3D 16543475 (Pubitemid 44061339)
- (2006) Blood , vol.108 , Issue.2 , pp. 432-440
- Meraouna, A.¹ Cizeron-Clairac, G.² Le Panse, R.³ Bismuth, J.⁴ Truffault, F.⁵ Tallaksen, C.⁶ Berrih-Aknin, S.⁷

22
- 17744392666
- Differential estrogen receptor expression in autoimmune myasthenia gravis
- DOI 10.1210/en.2004-1003
- P. Nancy S. Berrih-Aknin 2005 Differential estrogen receptor expression in autoimmune myasthenia gravis Endocrinology 146 5 2345 2353 10.1210/en.2004-1003 1:CAS:528:DC%2BD2MXjslamtLg%3D 15661863 (Pubitemid 40577522)
- (2005) Endocrinology , vol.146 , Issue.5 , pp. 2345-2353
- Nancy, P.¹ Berrih-Aknin, S.²

23
- 34248174458
- Polymorphisms of interferon-γ, interleukin-10, and interleukin-12 genes in myasthenia gravis
- DOI 10.1016/j.humimm.2007.02.003, PII S0198885907000407
- V. Yilmaz Y. Tütüncü N. Baris Hasbal Y. Parman P. Serdaroglu F. Deymeer, et al. 2007 Polymorphisms of interferon-γ, interleukin-10, and interleukin-12 genes in myasthenia gravis Hum Immunol 68 6 544 549 10.1016/j.humimm.2007.02.003 1:CAS:528:DC%2BD2sXlsFektbY%3D 17509455 (Pubitemid 46726854)
- (2007) Human Immunology , vol.68 , Issue.6 , pp. 544-549
- Yilmaz, V.¹ Tutuncu, Y.² Baris Hasbal, N.³ Parman, Y.⁴ Serdaroglu, P.⁵ Deymeer, F.⁶ Saruhan-Direskeneli, G.⁷

24
- 34249829243
- C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-γ are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells
- 1:CAS:528:DC%2BD2sXlsVOmur4%3D 17513756
- W. Wang M. Milani N. Ostlie D. Okita R.K. Agarwal R. Caspi, et al. 2007 C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-γ are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells J Immunol 178 11 7072 7080 1:CAS:528: DC%2BD2sXlsVOmur4%3D 17513756
- (2007) J Immunol , vol.178 , Issue.11 , pp. 7072-7080
- Wang, W.¹ Milani, M.² Ostlie, N.³ Okita, D.⁴ Agarwal, R.K.⁵ Caspi, R.⁶

25
- 63349109943
- Genetically determined neuromuscular disorders of some Roma families living in Hungary
- 19248726
- L. Aranka M. Peter K. Jeno R. Katalin T. Gyula E. Emoke, et al. 2009 Genetically determined neuromuscular disorders of some Roma families living in Hungary Ideggyogy Sz 62 1-2 41 47 19248726
- (2009) Ideggyogy Sz , vol.62 , Issue.12 , pp. 41-47
- Aranka, L.¹ Peter, M.² Jeno, K.³ Katalin, R.⁴ Gyula, T.⁵ Emoke, E.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.